{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:14:52Z","timestamp":1789398892376,"version":"build-2803163510"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:p>This case series describes multicenter experience with interleukin 6 (IL-6) receptor blockers used during attacks in aquaporin 4\u2013immunoglobulin G\u2013positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) and myelin oligodendrocyte glycoprotein antibody\u2013associated disease (MOGAD).<\/jats:p>","DOI":"10.1001\/jamaneurol.2026.1850","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:27Z","timestamp":1781537427000},"page":"935","source":"Crossref","is-referenced-by-count":0,"title":["IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD"],"prefix":"10.1001","volume":"83","author":[{"given":"Andreu","family":"Vilaseca","sequence":"first","affiliation":[{"name":"Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe-Antoine","family":"Bilodeau","sequence":"additional","affiliation":[{"name":"Division of Neuroimmunology, Department of Neurology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Lotan","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah-Tikva, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hellmann","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah-Tikva, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Neuroimmunology, Department of Neurology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"},{"name":"Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"},{"name":"Department of Neurology, Laboratory Medicine and Pathology, and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[{"name":"Division of Neuroimmunology, Department of Neurology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"},{"name":"Department of Neurology, Laboratory Medicine and Pathology, and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Kister","sequence":"additional","affiliation":[{"name":"NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Langone Medical Centre, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"nld260010r1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1474-4422(20)30078-8","article-title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.","volume":"19","author":"Traboulsee","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"nld260010r3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001076","article-title":"New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD.","volume":"8","author":"Takeshita","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"nld260010r4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome.","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"issue":"6","key":"nld260010r5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200150","article-title":"Dramatic response to anti-IL-6 receptor therapy in children with life-threatening myelin oligodendrocyte glycoprotein-associated disease.","volume":"10","author":"McLendon","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"nld260010r6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0042-1758447","article-title":"Plasma exchange in inflammatory demyelinating disorders of the central nervous system: reasonable use in the clinical practice.","volume":"81","author":"Queiroz","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"8","key":"nld260010r7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214926","article-title":"Role of tocilizumab in severe CNS inflammatory presentations in children.","volume":"106","author":"Marefi","year":"2026","journal-title":"Neurology"},{"key":"nld260010r2","author":"Levy","year":"2026"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2850382\/jamaneurology_vilaseca_2026_ld_260010_1789047975.54531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:01:04Z","timestamp":1789398064000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2850382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.1850","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}